In addition, high SPARC expression was associated with poor prognosis and survival in colorectal cancer, melanoma and oesophageal cancer (Porte et al, 1995; Massi et al, 1999; Thomas et al, 2000). This evidence concerns the gene SPARC and colorectal cancer.